Twitter | Search | |
Search Refresh
Nathan A. Pennell MD, PhD, FASCO May 24
Planning my virtual session, and by first impressions here are my top 5 abstracts. Thoughts?
Reply Retweet Like
Linnea Olson May 20
Clinical research has extended my life with stage IV lung cancer far beyond what was thought possible--diagnosed in April of 2005 & now in my 4th phase I clinical trial. It is my wish that all might have the opportunity to participate in trials.
Reply Retweet Like
Kim Moran-MacIntosh 🇨🇦 May 25
pts R further disadvantaged compared to pts with other cancers, Currently accounts for 26% of all cancer deaths & only receives less than 7% of the Research funding
Reply Retweet Like
FDA Oncology May 22
Today FDA approved brigatinib (ALUNBRIG, ARIAD Pharmaceuticals) for ALK-positive metastatic non-small cell lung cancer and the Vysis ALK Break Apart FISH Probe Kit (Abbott Molecular) as a companion diagnostic for brigatinib.
Reply Retweet Like
Kim Moran-MacIntosh 🇨🇦 May 23
What is the #1 Cancer killer of women, most would answer "breast cancer"; however, takes the lives of almost twice as many women. Only 19% of those Dx with will live 5 years+.
Reply Retweet Like
Haval Balata May 25
Our latest paper now online: 'Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD'
Reply Retweet Like
Ferma.AI May 25
Twitter is the new McCormick for . With 20.7 Million impressions in the last one week, the buzz has never been louder. To make sense of the overwhelming discussions, we created a bot to track the key sessions. Here is what we found about lung cancer ( ):
Reply Retweet Like
IASLC May 22
We're excited to announce the chairs for our 2021 World Conference on Lung Cancer () will be Drs. David Harpole, and Thomas Stinchcombe. We can't wait to work closely with this group of leaders to bring you another extraordinary meeting.
Reply Retweet Like
Dr. Antonio Calles 🌈😷 #QuédateEnCasa 6h
CM-9LA approved by before data presentation at or manuscript publication
Reply Retweet Like
GO2 Foundation for Lung Cancer May 24
Join us from the comfort and safety of your home on Tuesday, June 2 for our next Rapid Response Living Room. >>
Reply Retweet Like
Harpreet Singh, MD May 18
Today, FDA approved: ✅ Atezolizumab for 1L NSCLC with high PD-L1 expression ✅ q2, q3, and q4 dosing schedules approved
Reply Retweet Like
NatureRevClinOncol 15h
New article by Christian Rolfo & Alessandro Russo now live online: 'Liquid biopsy for early stage lung cancer moves ever closer' -
Reply Retweet Like
Manuel Dómine May 24
Sex is a strong prognostic factor in stage IV NSCLC patients, a new paper fromthe Spanish Lung Cancer Group (GECP) Tumor Registry.
Reply Retweet Like
IASLC 13h
Our latest "Lung Cancer Considered" eps. features leading PRAs, advocacy organizations and researchers and clinicians. Topical and timely, the episode addresses critical information that patients need to know in the era.
Reply Retweet Like
JTO May 23
JTO Research Watch: "Molecular mechanisms of acquired resistance to MET tyrosine kinase inhibitors in patients with MET exon 14 mutant ."
Reply Retweet Like
Dr. Antonio Calles 🌈😷 #QuédateEnCasa 6h
Replying to @Tony_Calles
CM-9LA: Toxicity profile of Nivolumab + Ipilimumab + 2 cycles of chemo compared to chemotherapy.
Reply Retweet Like
LuCa National Training Network 11h
Despite decades of research into tobacco use treatment, many PCPs still lack the knowledge of best approaches to assist patients in their attempts to quit smoking. Find training and tools to reduce your patients risk of at
Reply Retweet Like
John Edwards May 25
There's been a flurry of activity early this am before the first -Cancer data deadline, as the 1000th and case has been added. 👏👏👏 Don't worry, dear collaborators, there's plenty of time to add more cases, complete missing data or enrol
Reply Retweet Like
IASLC May 21
Potentially practice-changing studies will be presented at our WCLC 2020 Virtual Presidential Symposium on 8/8/20, serving as a prelude to our meeting (1/26-1/29, 2021). Interact with your peers and engage in real-time Q&A. Registration details coming soon!
Reply Retweet Like
Dr. Antonio Calles 🌈😷 #QuédateEnCasa May 24
Following initiative of planning Virtual , in the next days I will be sharing my top abstracts selection within the lung track to help navigate the program. Here are my and selection of abstracts. What do you think?
Reply Retweet Like